Moderna recently launched early stage clinical trials for an mRNA vaccine against the Epstein-Barr virus (EBV), a common pathogen that infects almost everyone at some point in their lives, is the primary cause of mononucleosis and, according to a study published in the journal Science Thursday, likely causes multiple sclerosis (MS), offering hope the devastating neurological condition might be prevented.

Read full story here.